London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
London startup Poolbeg Pharma is set to trial a drug aimed at preventing a side-effect of cancer therapy.
London startup Poolbeg Pharma is set to trial a drug aimed at preventing a side-effect of cancer therapy.
The article reviews the efficacy, dosage, and mechanism of Lion's Mane Mushroom.
Research suggests that parrots may use names rather than merely repeating words.

The article discusses the potential of pharmacogenomic testing in improving pain management by personalizing prescriptions.

The article reflects on lessons learned from supervising students in biotechnology.
The piece explores a fitness hack that may enhance longevity through short, intensive activity.

The global biotech ingredients market is witnessing significant growth due to advances in synthetic biology.
The article discusses a CRISPR technology that selectively targets and destroys cancer cells.
The article discusses research findings by the CDC on the rise of drug-resistant infections.

The article discusses a new pharmaceutical drug-discovery model that efficiently identifies thousands of toxins.
The report covers the competitive landscape of obesity drugs and the ongoing innovations in this pharmaceutical race.

Research indicates that social inequality is linked to faster biological aging, with implications for children.

The article discusses how prompt-to-drug technology powered by artificial intelligence is reducing the timelines for pharmaceutical research and development.
A pioneering NHS trial using genetically modified therapy shows remission results in lupus patients.

Most ideas don’t arrive as breakthroughs.

Breakthroughs in infertility research demonstrate advancements in stem cell embryos.

The article reports on the beginning of the first human trial of a reverse-aging drug.
The article discusses how generative AI is fueling the growth of Indian startups and transforming business models.
Longevity startups are attracting investors and advancing technology in the biotech sector.
Our ancestors' genomes were built through successive waves of gene transfers.

The article discusses biohacking techniques aimed at enhancing longevity through monitoring biological metrics.
The FDA has approved Sanofi's new diabetes drug specifically for children with stage 3 diabetes.
New research suggests GLP-1 drugs could reduce cancer risk.

This piece offers insights into choosing the right stem cell therapy clinics, emphasizing careful selection for hopeful patients.

A study identified 74 locations in the genome linked to anxiety symptoms, with many previously reported and some novel genetic loci.
The article discusses consumer openness to purchasing milk from gene-edited cows amid challenges faced by dairy farmers in New Zealand.
The article discusses the development and potential of new obesity medications and their effectiveness.

Insilico Medicine's AI-driven approaches to drug development showcase its potential in the biotechnology field.
The article discusses the potential of 'synthetic lethality' as a new approach for cancer treatment that could impact the biotechnology industry.
This paper explores the application of genetic algorithms with optimization guided operators in machine learning.

The article discusses the author's experience building a successful side hustle using AI in a short period.

The article discusses the sympathetic-parasympathetic imbalance theory of aging and its implications for the hallmarks of aging.
The article discusses the importance of addressing pelvic motion issues after hip replacement surgery, highlighting research insights.
Researchers at Princeton University have developed an AI system to sort cell droplets and study drug effects in human cells.
Scientists have uncovered a surprising new genetic cause of a rare movement disorder.

The article explores the role of the longevity enzyme PON1 in HDL cholesterol and its implications for health.
Scientists have developed a blood test that can detect thousands of genetic conditions during pregnancy by examining fragments of fetal DNA in the mother’s bloodstream.
The article discusses the implications of a discontinued cancer drug and a security breach affecting Novo.
The nonprofit Blood Cancer United is purchasing an experimental cancer drug to ensure patient access.

The piece reflects on Elon Musk's achievement of becoming the first trillionaire and its implications for the future economy.
The article reveals insights from cancer research that may lead to new treatment strategies for pancreatic tumors.

The article covers how generative AI is being employed to simulate eligibility for clinical trials.
Gene Shalit, a longtime movie critic known for his distinctive style and humor, has passed away at the age of 100.
The article explores the impact of a viral gene from the Jurassic era that may influence the reproductive behavior of apple snails.
The rapid genetic adaptation of the wasp spider is observed as it expands into northern Europe over a few decades.
Researchers have developed lab-grown canine muscle cells to offer a more efficient solution for early therapeutic testing.
The report discusses trends in the global ashwagandha market, particularly its growth related to stress relief and wellness.
A research team in Japan has developed a novel nanowire device capable of rapidly and noninvasively detecting cancer.
Vivek Natarajan, a research scientist at Google DeepMind, is focused on developing AI to find cures for diseases such as Parkinson's.
Researchers discovered that declining levels of phosphatidylcholine may be a major factor in aging cells that can potentially be reversed.
Describe what you care about in plain English. MyFeed scans thousands of sources and delivers only what matters to you.
Popular feeds